US · PETS
PetMed Express, Inc.
- Sector
- Healthcare · Medical - Pharmaceuticals
- Headquarters
- Delray Beach, FL 33445
- Website
- 1800petmeds.com
Price · as of 2025-03-31
$2.30
Market cap 58.64M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $28.74 | +1,149.57% |
| Intrinsic Value(DCF) | $2.38 | +3.48% |
| Graham-Dodd Method(GD) | $1.19 | -48.48% |
| Graham Formula(GF) | $2.53 | +10.17% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $6.78 | $28.72 | $1.95 | $1.80 | $5.05 |
| 2012 | $7.25 | $39.42 | $1.74 | $0.00 | $8.73 |
| 2013 | $8.48 | $36.16 | $0.65 | $0.00 | $3.38 |
| 2014 | $9.15 | $27.06 | $0.60 | $0.00 | $9.41 |
| 2015 | $12.06 | $32.97 | $1.85 | $0.00 | $5.59 |
| 2016 | $13.73 | $40.01 | $2.28 | $0.00 | $10.66 |
| 2017 | $26.69 | $39.41 | $4.19 | $0.00 | $16.55 |
| 2018 | $30.73 | $45.71 | $10.93 | $1.97 | $32.08 |
| 2019 | $13.73 | $30.49 | $13.25 | $0.00 | $21.35 |
| 2020 | $29.62 | $42.82 | $6.02 | $0.00 | $10.73 |
| 2021 | $28.70 | $36.97 | $7.09 | $0.00 | $17.45 |
| 2022 | $19.13 | $52.92 | $5.39 | $0.00 | $0.00 |
| 2023 | $14.34 | $28.16 | $4.06 | $0.00 | $0.56 |
| 2024 | $4.34 | $259.24 | $2.72 | $0.00 | $0.00 |
| 2025 | $3.96 | $28.74 | $2.07 | $1.19 | $2.53 |
AI valuation
Our deep-learning model estimates PetMed Express, Inc.'s (PETS) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $28.74
- Current price
- $2.30
- AI upside
- +1,149.57%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.38
+3.48% upside
Graham-Dodd
$1.19
-48.48% upside
Graham Formula
$2.53
+10.17% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| PETS | PetMed Express, Inc. | $2.30 | 58.64M | +1,150% | +3% | -48% | +10% | -13.01 | 0.96 | 0.36 | 4.15 | — | 1.81 | 30.46% | -0.67% | -2.76% | -6.90% | -4.12% | -3.94% | 0.01 | — | 1.26 | 0.91 | -8.01 | -1892.00% | -1719.00% | 10361.00% | -0.48% | 0.08 | -1.06% | 0.22% | -2.90% | 0.22% | -18.19 | -70.47 | 0.12 | 3.02 |
| BDSX | Biodesix, Inc. | $15.33 | 121.96M | +481% | +136% | — | — | -3.37 | -48.25 | 1.34 | -7.90 | — | -5.56 | 75.25% | -31.50% | -39.85% | -383.09% | -51.61% | -38.18% | -29.56 | -3.61 | 1.86 | 1.61 | -2.46 | -2924.00% | 2408.00% | -5464.00% | -19.79% | -1.33 | -43.57% | 0.00% | 0.00% | 0.42% | -6.20 | -7.34 | 1.95 | -7.01 |
| CTSO | Cytosorbents Corporation | $0.75 | 47.26M | +3,558% | -47% | — | — | -2.65 | 4.95 | 1.54 | -5.17 | — | 7.47 | 70.59% | -47.16% | -58.21% | -120.52% | -49.92% | -41.18% | 2.42 | -12.00 | 2.20 | 1.08 | -1.55 | -4154.00% | 1451.00% | -3488.00% | -26.76% | -1.47 | -47.32% | 0.00% | 0.00% | 0.00% | -4.68 | -5.34 | 2.21 | -8.19 |
| FBIO | Fortress Biotech, Inc. | $3.42 | 106.15M | +410% | -82% | — | +1,342% | -0.26 | 1.41 | 0.55 | -0.49 | — | -3.51 | 63.80% | -191.38% | -79.75% | -533.80% | -308.14% | -77.53% | 3.34 | -11.12 | 1.27 | 0.95 | -0.18 | -6824.00% | -3176.00% | -3017.00% | -297.40% | -1.12 | -265.74% | 14.72% | -3.90% | 14.72% | -0.46 | -0.53 | 0.88 | -9.03 |
| GNTA | Genenta Science S.p.A. | $0.99 | 18.96M | — | — | — | — | -6.66 | 4.75 | — | -4.80 | — | 4.78 | 0.00% | — | — | -54.13% | -1295.77% | -47.95% | 0.00 | — | 6.89 | 6.72 | 0.47 | -2344.00% | — | -4434.00% | -10.53% | -2.97 | -828.69% | 0.00% | 0.00% | 1.48% | -4.78 | -7.48 | — | 8.82 |
| ICCM | IceCure Medical Ltd | $0.58 | 39.85M | +4,441% | -7% | — | — | -4.48 | 9.95 | 20.87 | -4.01 | — | 9.95 | 44.09% | -476.94% | -465.45% | -160.70% | -2098.40% | -105.69% | 0.07 | — | 1.95 | 1.41 | 0.46 | -625.00% | 192.00% | -282.00% | -18.39% | -2.28 | -1689.04% | 0.00% | 0.00% | 0.00% | -3.92 | -4.87 | 18.71 | -7.83 |
| MDAI | Spectral AI, Inc. | $1.40 | 42.96M | +2,693% | -59% | — | — | -1.69 | -3.56 | 0.87 | -2.21 | — | -3.56 | 44.87% | -22.25% | -51.77% | 341.85% | 101.83% | -134.42% | -0.65 | -2.22 | 0.57 | 0.43 | 0.04 | -4257.00% | 6383.00% | -3052.00% | -35.62% | -0.52 | 142.31% | 0.00% | 0.00% | 0.00% | -3.85 | -2.76 | 0.86 | -4.86 |
| MDCX | Medicus Pharma Ltd. Commo… | $1.53 | 37.8M | — | — | — | — | -2.63 | 9.36 | — | -2.29 | — | 9.36 | 0.00% | — | — | -525.44% | 1700.21% | -295.90% | 0.10 | -35.21 | 2.33 | 1.81 | 0.34 | -2810.00% | — | 14643.00% | -34.93% | -4.44 | 1558.23% | 0.00% | 0.00% | 7.24% | -2.28 | -2.49 | — | -6.04 |
| RNTX | Rein Therapeutics Inc. | $1.14 | 29.97M | — | — | — | — | -0.57 | 0.66 | — | -0.81 | -21.57 | 6.09 | 0.00% | — | — | -205.24% | -408.03% | -71.76% | 0.00 | — | 2.38 | 2.24 | 0.46 | 263.00% | — | 1254.00% | -62.45% | -3.88 | -143.12% | 0.00% | 0.00% | 0.00% | -0.35 | -1.02 | — | -8.63 |
| TELA | TELA Bio, Inc. | $0.87 | 38.66M | +2,769% | +12% | — | — | -1.82 | 2.43 | 1.00 | -1.88 | — | 2.58 | 67.08% | -49.23% | -54.60% | -159.87% | -201.31% | -45.76% | 1.51 | -6.45 | 5.01 | 4.02 | 0.30 | -3480.00% | 1856.00% | 269.00% | -61.69% | -2.67 | -252.24% | 0.00% | 0.00% | 8.18% | -1.74 | -1.40 | 0.86 | -4.68 |
| YI | 111, Inc. | $7.91 | 68.56M | +302% | -56% | — | — | -25.62 | -0.83 | 0.04 | 13.27 | — | -0.83 | 5.76% | 0.01% | -0.45% | 3.39% | -0.26% | -0.71% | -0.40 | 0.07 | 1.13 | 0.47 | -8.35 | -8386.00% | -366.00% | -15422.00% | 46.56% | 0.11 | -30.18% | 0.00% | 0.00% | 8.50% | 154.56 | 1.32 | 0.02 | 3.48 |
About PetMed Express, Inc.
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
- CEO
- Leslie C. G. Campbell
- Employees
- 287
- Beta
- 0.72
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.38 ÷ $2.30) − 1 = +3.48% (DCF, example).